DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 93 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Astec LifeSciences Limited — Spurt in Volume

NSE 46 min ago·1 Oct 2026, 5:28 am

Astec Lifesciences

Astec LifeSciences Limited has reported a significant rise in trading volume for its shares. The stock exchange, concerned about the unusual activity, had written to the company requesting an explanation. In response, Astec has submitted a formal statement to the exchange to inform the market and safeguard investor interests.

This development indicates heightened market interest in the company, though the specific reasons behind the volume spike remain undisclosed. For investors, this is a signal to pay close attention to the company's official disclosures for clarity on the situation.

Investors should watch for the company's detailed response to the exchange. Any explanation regarding the volume surge, such as a corporate announcement or market rumor, will be crucial for understanding the stock's future direction.